title: Cellular therapies supplement: strategies for improving transplant efficiency in the context of cellular therapeutics.
abstract: The field of hematopoietic stem cell transplantation (HSCT) has overcome many obstacles that have led to our current clinical ability to utilize cells collected from marrow, mobilized peripheral blood, or umbilical cord blood for the treatment of malignant and nonmalignant hematologic diseases. It is in this context that it becomes evident that future progress will lie in our development of an understanding of the biology by which the process of HSCT is regulated. By understanding the cellular components and the mechanisms by which HSCT is either enhanced or suppressed it will then be possible to design therapeutic strategies to improve rates of engraftment that will have a positive impact on immune reconstitution post-HSCT. In this review we focus primarily on allogeneic hematopoietic stem cell transplantation (allo-HSCT), the current challenges associated with allo-HSCT, and some developing strategies to improve engraftment in this setting.
authors.affiliation: Section of Hematology & Section of Bone Marrow Transplant and Cell Therapy, Division of Hematology/Oncology/Cell Therapy, Rush University Medical Center, Chicago, Illinois 60612, USA.
authors.forename: Antonio
authors.initials: A
authors.lastname: Jimenez
authors.forename: Henry C
authors.initials: HC
authors.lastname: Fung
authors.forename: Kent W
authors.initials: KW
authors.lastname: Christopherson
mesh_terms: D000818:Animals; D017690:Cell Transplantation / Q000379:methods*; D002986:Clinical Trials as Topic; D018819:Dipeptidyl Peptidase 4 / Q000502:physiology; D004526:Efficiency; D005544:Forecasting; D006082:Graft Enhancement, Immunologic / Q000379:methods; D006084:Graft Rejection; D006402:Hematologic Diseases / Q000601:surgery; D019650:Hematopoietic Stem Cell Mobilization / Q000379:methods; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects / Q000379:methods; D006801:Humans; D016867:Immunocompromised Host; D051379:Mice; D039902:Multipotent Stem Cells / Q000637:transplantation; D009369:Neoplasms / Q000601:surgery; D009894:Opportunistic Infections / Q000209:etiology / Q000276:immunology / Q000517:prevention & control
chemical_list: D018819:Dipeptidyl Peptidase 4; C545245:Dpp4 protein, mouse